These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12455769)

  • 41. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.
    Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP
    J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients.
    Hamulu A; Dişcigil B; Ozbaran M; Calkavur T; Kara E; Kokuludağ A; Büket S; Bilkay O
    Perfusion; 1996 Jul; 11(4):333-7. PubMed ID: 8884862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation.
    Nilsson B; Larsson R; Hong J; Elgue G; Ekdahl KN; Sahu A; Lambris JD
    Blood; 1998 Sep; 92(5):1661-7. PubMed ID: 9716594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement and biocompatibility.
    Mollnes TE
    Vox Sang; 1998; 74 Suppl 2():303-7. PubMed ID: 9704460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery.
    van der Kamp KW; van Oeveren W
    Int J Artif Organs; 1993 Dec; 16(12):836-42. PubMed ID: 8175200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
    Kagisaki K; Masai T; Kadoba K; Sawa Y; Nomura F; Fukushima N; Ichikawa H; Ohata T; Suzuki K; Taketani S; Matsuda H
    Artif Organs; 1997 Jul; 21(7):836-40. PubMed ID: 9212969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules.
    Garred P; Mollnes TE
    Artif Organs; 1997 Apr; 21(4):293-9. PubMed ID: 9096801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antithrombin III regulates complement activity in vitro.
    Weiler JM; Linhardt RJ
    J Immunol; 1991 Jun; 146(11):3889-94. PubMed ID: 2033259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
    Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
    Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An in vitro study of blood compatibility of vascular grafts made of bacterial cellulose in comparison with conventionally-used graft materials.
    Fink H; Hong J; Drotz K; Risberg B; Sanchez J; Sellborn A
    J Biomed Mater Res A; 2011 Apr; 97(1):52-8. PubMed ID: 21308986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation.
    Borowiec J; Jaramillo A; Venge P; Nilsson L; Thelin S
    Cardiovasc Surg; 1997 Dec; 5(6):568-73. PubMed ID: 9423940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of complement consumption and platelet accumulation between membrane oxygenators coated with a polymer or heparin.
    Tagaya M; Murataka T; Okano S; Handa H; Takahashi S
    Perfusion; 2024 Sep; 39(6):1143-1151. PubMed ID: 37216953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin free long-term extracorporeal circulation using bioactive surfaces.
    Mottaghy K; Oedekoven B; Pöppel K; Bruchmüller K; Kovacs B; Spahn A; Geisen C
    ASAIO Trans; 1989; 35(3):635-7. PubMed ID: 2512973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental studies on three types of heparin-coated cardiopulmonary bypass circuits.
    Baba T; Morisita K; Sakata J; Ito T; Hachiro Y; Kazui T; Abe A; Komatu S
    Artif Organs; 1997 Jul; 21(7):779-81. PubMed ID: 9212957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A heparin-coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit.
    Plötz FB; van Oeveren W; Hultquist KA; Miller C; Bartlett RH; Wildevuur CR
    Artif Organs; 1992 Aug; 16(4):366-70. PubMed ID: 10078276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.